Why Automate Adhesive Placement Now? A Smarter Path from Medical Device Development to Production

How semi-automatic assembly can help medical-device manufacturers validate their manufacturing process early and scale with confidence.

For medical-device startups and growing manufacturers, automation can seem like a decision best left until production volumes justify the investment.

Early in development, manual assembly is often the practical choice. Product designs are evolving, production volumes are limited, and engineering teams are focused on proving that their devices work as intended.

But what if manufacturers could begin validating their actual adhesive-placement process long before they are ready for fully automated production?

With AccuPlace, manufacturers can move from manual assembly to semi-automatic assembly early in product development, using the same core placement technology that can carry forward into full automation.

This approach gives engineering teams an opportunity to evaluate critical aspects of their manufacturing process before production ramps up. Rather than waiting until higher volumes demand automation, companies can begin developing and validating their placement process while the product is still taking shape.

Start small. Validate early. Scale when you’re ready.

One of the challenges facing emerging medical-device companies is balancing the need to control costs today with the need to establish a reliable manufacturing process for tomorrow.

Investing in a fully automated production line too early may not make economic sense. Yet relying exclusively on manual assembly can leave important questions about process performance unanswered.

AccuPlace offers a practical path between these two stages.

Manufacturers can begin with manual assembly and then introduce semi-automatic AccuPlace equipment as their development progresses. This allows them to evaluate the actual placement process while an operator continues to handle the material loading and unloading.

Importantly, semi-automatic assembly is not simply a temporary workaround. It can provide a meaningful opportunity to evaluate the same fundamental placement technology intended for the fully automated process.

That distinction can make a significant difference for a company developing a new medical device.

1. Validate the manufacturing process before production scales

When placing an adhesive component, successful assembly involves more than putting the component in the right location.
Depending on the application, manufacturers may need to understand how the adhesive releases from its liner, how pressure is applied, how the adhesive wets out across the target surface, and how the completed assembly performs.

These factors can influence the suitability of a placement process for the intended application.

With semi-automatic AccuPlace equipment, manufacturers can evaluate these critical aspects of placement while an operator manually loads and unloads the parts.

This creates an opportunity to investigate questions such as:
Does the component release from its liner as expected?
Can the placement process achieve the required positioning?
Is the applied pressure appropriate for the application?
Does the adhesive wet out as intended?
Does the assembled component meet the relevant performance requirements?
Are there material-handling or process variables that need further attention?
The answers depend on the materials, component design, equipment configuration, and application requirements. But investigating them early can help manufacturers identify potential problems before committing to higher-volume production.
The objective is to validate the placement process early—not wait until full automation is required to discover what works and what needs improvement.

For medical-device manufacturers, this early process understanding can help inform engineering decisions and support the development of a more controlled manufacturing approach.

2. Semi-automatic assembly provides a bridge to full automation
Traditionally, moving from manual assembly to automated production can feel like a major transition. Companies may worry that the process developed during early production will need to be redesigned when volumes increase.
AccuPlace offers a different approach.
Its semi-automatic equipment allows manufacturers to develop and evaluate the placement process while an operator handles the loading and unloading of the target parts.
When production requirements eventually justify full automation, the fundamental placement technology can remain the same. The key change is how the parts are moved into and out of the placement position.
In other words, manufacturers can establish and evaluate the core placement process before automating material handling.
This continuity can help reduce uncertainty as a product moves from development toward production. Rather than introducing an entirely different placement approach at a later stage, the manufacturer can build on the process already evaluated using the semi-automatic equipment.
The specific transition will depend on the application and required system configuration, but the underlying principle is straightforward:
Develop the placement process early. Automate material handling when production demands it.

3. Avoid waiting for production volume to reveal process problems
A process that works during prototype assembly may face different challenges when production increases.
Operators may need to work faster. Consistency may become more difficult to maintain. Labor requirements may grow, and manufacturers may need to establish more repeatable production methods.

If the placement process has not been adequately evaluated, these changes can expose problems at a time when the business is under pressure to deliver product.

By introducing semi-automatic assembly earlier, manufacturers can begin investigating placement performance before reaching that point.

They can evaluate components, refine process parameters, assess assembly results, and identify potential handling issues while production volumes remain manageable.

This does not eliminate the need for further process qualification, validation, or testing where required. Nor does it guarantee that every aspect of a future automated production system will perform identically without additional evaluation.

It does, however, provide a valuable opportunity to establish a technical foundation before production requirements increase.

4. A practical approach for medical-device startups

For smaller medical-device companies, the economics of automation can be particularly challenging.
A startup may have a promising product but limited production volumes, constrained capital, and an uncertain commercialization timeline. Fully automated production may not yet be justified.
At the same time, the company needs to understand how its product will be manufactured consistently as it progresses toward commercialization.

A staged approach can help balance these competing priorities.

Stage 1: Manual assembly
Begin with manual assembly when appropriate for early prototypes and development work. Establish the basic assembly requirements and identify potential placement challenges.
Stage 2: Semi-automatic placement
Introduce semi-automatic AccuPlace equipment to evaluate the actual placement process. Investigate liner release, pressure, adhesive wet-out, positioning, and application-specific performance while an operator handles the parts.
Stage 3: Process refinement and evaluation
Use the results to refine the process and identify any outstanding technical questions. Determine what additional testing, documentation, or validation is necessary for the intended application.

Stage 4: Full automation

When production volumes and business requirements justify it, evaluate full automation. Material handling can be automated while retaining the same core placement technology, subject to the requirements of the final system.

This approach allows the company to make manufacturing decisions progressively, based on its development stage and production needs.

It also gives engineering and operations teams a clearer understanding of the placement process before making the next investment.

5. Why early process evaluation matters in medical-device manufacturing

Medical devices often incorporate adhesive components that perform important functions within the finished product.
These may include seals, films, tapes, die-cut adhesive parts, foam components, and other materials used in device assembly.
Depending on the application, component placement and adhesive performance may affect sealing, assembly integrity, device functionality, or other critical requirements.

For this reason, selecting a placement process should involve more than evaluating equipment speed or the cost per assembly.
Manufacturers need to understand how the process interacts with their actual materials, components, substrates, and performance requirements.

Semi-automatic placement provides an opportunity to investigate these relationships before investing in a fully automated material-handling system.

For startups in particular, this can help bridge the gap between proving a product concept and developing a manufacturing process suitable for the next stage of commercialization.

6. When should you evaluate AccuPlace for your application?

You don’t have to be approaching mass production to begin the conversation.
An application evaluation may be worthwhile if:
Your medical device uses die-cut adhesive components, films, tapes, seals, foam parts, or labels.
You need to understand how liner release, pressure, or adhesive wet-out affects the assembly.
You want to evaluate placement accuracy and repeatability before scaling production.
You are moving from prototype development toward pilot production.
You need a practical path from manual assembly to semi-automatic placement and eventually full automation.
You want to investigate manufacturing feasibility before committing to a larger automation investment.
Useful starting information includes component drawings or samples, substrate details, placement requirements, current assembly methods, and expected production volumes.
You don’t need to have every manufacturing question answered. In fact, identifying those questions is one of the reasons to evaluate the application early.
Build your manufacturing process before you need to scale it
For emerging medical-device manufacturers, the decision to automate doesn’t have to be an all-or-nothing commitment made at the beginning of development.
With AccuPlace, companies can start with manual assembly, progress to semi-automatic placement, and evaluate the actual placement process before deciding when to automate material handling.
This creates an opportunity to investigate critical process variables early, refine the manufacturing approach, and establish a technical foundation for future production.
When the time comes to scale, the transition can build on the same core placement technology rather than requiring an entirely different placement process.
The advantage isn’t simply automating sooner. It’s learning how to manufacture your product reliably before production growth makes that knowledge more urgent.
Explore your application with AccuPlace
Are you developing a medical device that relies on precisely placed adhesive components?
AccuPlace can help you explore your placement requirements and determine whether a manual-to-semi-automatic-to-fully-automatic approach is appropriate for your application.
Start by discussing your component, substrate, placement requirements, and production goals with the AccuPlace team.
Contact AccuPlace to Discuss Your Application